Tumour necrosis factor receptor 1 inhibition and cardiovascular disease: a cis-Mendelian randomization study

Back

EAPC Premium Access

Tumour necrosis factor receptor 1 inhibition and cardiovascular disease: a cis-Mendelian randomization study

Session: Young Investigators Award - Population Science and Public Health

Topic: Cardiovascular Epidemiology

Speaker: Doctor S. Rajasundaram (London, GB)

Event: ESC Preventive Cardiology 2023

Congress Presentation

Add to my library

About the speaker

Doctor Skanda Rajasundaram

University of Oxford and Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

4 more presentations in this session

Outcome of a nationwide screening programme in young individuals

Speaker: Doctor H. MacLachlan (London, GB)

Trends in glycemic, blood pressure, and lipid control in adults with diabetes in Switzerland

Speaker: Doctor A. Alkandari (Kuwait City, KW)

Novel insights into cardiovascular ageing in the general population using machine learning

Speaker: Doctor M. Shah (London, GB)

External validation of Systematic COronary Risk Evaluation 2 - Older Persons (SCORE2-OP) in the EPIC-Norfolk prospective population study

Speaker: Ms T. Van Trier (Amsterdam, NL)

Access the full session

Young Investigators Award - Population Science and Public Health

Speakers: Doctor S. Rajasundaram, Doctor H. MacLachlan, Doctor A. Alkandari, Doctor M. Shah, Ms T. Van Trier

Access

Video

About the event

ESC Preventive Cardiology 2023

13 April - 15 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources